Cisplatin Neurotoxicity Presenting as Reversible Posterior Leukoencephalopathy Syndrome
AJNR 19:415-417, 5911998., Ito,Y.,et al, 1998
Acute Leukoencephalopathies:Differential Diagnosis and Investigation
The Neurologist 4:148-166, Weinshenker,B.G.,et al, 1998
Computed Tomographic Changes of Hypertensive Encephalopathy
AJNR 6:395-398, Weingarten,K.L.,et al, 1985
Hypertensive Encephalopathy:A Clinicopathologic Study of 20 Cases
Neurol 28:928-939, Chester,E.M.,et al, 1978
Posterior Reversible Encephalopathy Syndrome in Infection, Sepsis, and Shock
AJNR 27:2179-2190, Bartynski,W.S.,et al, 2006
Reversible Posterior Leukoencephalopathy Syndrome
Intern Med J 35:83-90, Stott,V.L.,et al, 2005
Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping
Nueroradiology 46:978-983, Ahn, K.J.,et al, 2004
Thrombotic Thrombocytopenic Purpura:Brain CT and MRI Findings in 12 Patients
Neurol 52:1285-1288, Bakshi,R.,et al, 1999
Diffusion-Weighted Imaging Discriminates Between Cytotoxic & Vasogenic Edema in a Pt with Eclampsia
Stroke 28:1082-1085, Schaefer,P.W.,et al, 1997
A Reversible Posterior Leukoencephalopathy Syndrome
NEJM 334:494-500, Hinchey,J.,et al, 1996
Hypertensive Encephalopathy:Findings on CT, MR Imaging, and SPECT Imaging in 14 Cases
AJR 159:379-383, Schwartz,R.B.,et al, 1992
Adverse Drug Effects Attributed to Phenylpropanolamine:A Review of 142 Case Reports
Am J Med 89:195-208, Lake,C.R.,et al, 1990
Hypertensive Encephalopathy:Diffuse Reversible White Matter CT Abnormalities
Ann Neurol 18:268-270, Fisher,M.,et al, 1985
Computerized Tomographic Appearance of Hypertensive Encephalopathy
Arch Neurol 37:310-311, Rail,D.L.,et al, 1980
Eclampsia
NEJM 289:976, 1973; 290:344974., Jewett,J.F., 1974
Protecting Renal Function in Hypertensive Crisis
Hosp Phys 4:55, Kaplan,N.M., 1973